News

Cells were collected and lyzed by using the RIPA lysis buffer (Beyotime, China) containing the complete protease inhibitor cocktail (Roche) and phosphatase inhibitors (Sigma Aldrich, St. Louis, MO, ...
Rat C6 glioma cells were cultured at 37°C under a humidified atmosphere with 5% CO2 with a complete medium DMEM supplemented ... with 50 µg/ml PMSF (Roche) and a protease inhibitor cocktail (Roche).
Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...
OTCMKTS RHHBY opened at $37.65 on Thursday. The stock has a fifty day simple moving average of $41.40 and a 200-day simple moving average of $38.72. The company has a current ratio of 1.26, a ...
Roche and deCODE Announce Collaboration to Co-Develop PDE4 Inhibitors for Vascular Diseases NUTLEY, N.J. and BASEL, Switzerland and REYKJAVIK, Iceland, Nov. 23 ...
Two months after U.S. President Donald Trump issued an executive order proclaiming diversity, equity and inclusion (DEI) programs “illegal and immoral,” Roche has scrapped its high-profile ...
Roche and deCODE Announce Collaboration to Co-Develop PDE4 Inhibitors for Vascular Diseases deCODE will work on optimizing and bringing into clinic trials compounds the companies have identified ...
James Mangold received his first best director nomination at the Oscars for “A Complete Unknown” while his previous films “Logan,” “Ford v Ferrari” and “Walk the Line” also ...
ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies ...
The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned development of RG6206, a myostatin inhibitor. The Swiss group revealed the ...